MBRX

Conviction 67HealthcareScan · Thu, Jun 25, 2026

MBRX$3.00+2.22%

ResistanceSupportVol 14

Vol MA14 1.08M

Mar 26Apr 14May 1May 19Jun 8Jun 25

Moleculin Biotech, Inc.PHARMACEUTICAL PREPARATIONSwww.moleculin.com ↗

Price3.00

Change+2.22%

Gap-1.02%

Rel volume0.53×

Avg volume850.16K

Avg $ vol2.34M

SMA 202.68

SMA 502.53

SMA 2002.44

Price vs 50+18.29%

Price vs 200+22.73%

MA stackbullish

50/200 cross—

Supertrendup · 2.45

RSI (14)61

MACD hist0.04

MACD crossbull · 9d

Stoch %K / %D80 / 67

ADX (14)20

+DI / −DI29 / 18

RSI divergence—

MACD divergenceBearish

ATR %+7.64%

ADR %8.00%

52w high7.71

52w low0.2727

From 52w high-61.15%

Above 52w low+998.28%

New 52w highNo

SqueezeOff

Bollinger width29.64%

%B0.90

Donchian pos79.88%

Donchian high3.16

Donchian low2.34

AVWAP (52w high)3.33

vs AVWAP high-10.16%

AVWAP (52w low)2.81

vs AVWAP low+6.62%

OBV trendDown

Chaikin MF (20)0.28

Today vs 20d0.53×

Avg vol (14d)1.08M

Avg vol (20d)850.16K

Avg $ vol (20d)2.34M

Market cap15.98M

RS 3m (vs SPY)+17.97%

RS 6m (vs SPY)-32.61%

RS line new highNo

Trend template5/8

Technical rank62.4

1 week+6.96%

1 month+22.24%

3 months+20.28%

6 months-25.31%

1 year+886.82%

YTD-17.27%

P/E-0.48

P/B1.05

P/S—

P/FCF-0.70

EPS-0.5900

Div yield—

ROE-221.04%

ROA-143.65%

Debt/Eq—

Current1.38

EV/EBITDA-0.23

Gross margin—

Net margin—

Rev growth—

EPS growth-28.84%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value5.67M

Revenue0

Net income-12.85M

Gross profit—

Free cash flow-22.73M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out5.34M

Employees17

ListedThu, Jun 2, 2016

Free float4.93M

Float %92.4%

Short interest828.96K

Days to cover3.1d

Short volume32.5%

Squeeze score49 / 100

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeB

Conviction67 / 100

Pattern quality—

Tech rank62.4 / 100

Group rank50 / 100

Status laneNo active setup

Setup direction—

Pattern family

Resistance3.06

Support2.17

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in MBRX

All disclosures →

No recent disclosed trades by Congress in MBRX. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in MBRX

No recent insider (Form 4) filings in MBRX. Insiders must file within two business days of a trade.

SEC filings

EDGAR filings in MBRX · 1 recent

EDGAR →

8-K8-KFri, Jun 5, 2026

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.